Cost effectivenes of erlotinib versus chemotherapy for first-line treatment of non small cell lung cancer (NSCLC) in fit elderly patients participating in a prospective phase 2 stu...

por Christos, Chouaid, Hervé, Le Caer, Chrystelle, Locher, Cecile, Dujon, Pascal, Thomas, Jean Bernard, Auliac, Isabelle, Monnet, Alain, Vergnenegre
Publicado 2012